📰 **AstraZeneca stock falls after FDA panel votes against new cancer drug**

The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.

🔗 https://www.cnbc.com/2026/05/01/astrazeneca-stock-az-fda-panel-cancer-drug.html

#markets #news